The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates.

Source:http://linkedlifedata.com/resource/pubmed/id/9490274

Download in:

View as

General Info

PMID
9490274